Your browser doesn't support javascript.
loading
What Is the Optimal Antithrombotic Therapy for Valsalva Thrombus Following Transcatheter Aortic Valve Replacement?
Kato, Yuta; Kawahira, Yuto; Miyazaki, Midori; Hirata, Tetsuo; Kuwahara, Go; Sugihara, Makoto; Miura, Shinichiro.
Afiliação
  • Kato Y; Department of Cardiology, Fukuoka University Hospital, Fukuoka, Japan.
  • Kawahira Y; Department of Cardiology, Fukuoka University Hospital, Fukuoka, Japan.
  • Miyazaki M; Department of Clinical Laboratory and Transfusion, Fukuoka University Hospital, Fukuoka, Japan.
  • Hirata T; Department of Cardiology, Fukuoka University Hospital, Fukuoka, Japan.
  • Kuwahara G; Department of Cardiovascular Surgery, Fukuoka University Hospital, Fukuoka, Japan.
  • Sugihara M; Department of Cardiology, Fukuoka University Hospital, Fukuoka, Japan.
  • Miura S; Department of Cardiology, Fukuoka University Hospital, Fukuoka, Japan.
JACC Case Rep ; 29(16): 102455, 2024 Aug 21.
Article em En | MEDLINE | ID: mdl-39295789
ABSTRACT
Thrombus formation between the native sinus of Valsalva and the implanted transcatheter heart valve is a rare complication that may be associated with an increased risk for thrombotic complications. This paper presents the course of 3 cases with Valsalva thrombus, with a focus on the management of antithrombotic therapy.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article